Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

If there’s any one benefit to having a cat as a pet instead of a dog, it’s that they’re a bit more independent and able to care for themselves for many days without human intervention. The only thing ...